The administration of OSU-03012, a synthetic compound acting as a 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitor, elicits ACD in HCC cells differently from other tumor types where it triggers apoptosis. Here, PDK1 is linked to hepatocellular carcinoma.